|
(A) Enriched GO terms (DAVID)
|
|
1
|
15.19
|
GO:0098609~cell-cell adhesion
|
P07355, P62820, Q8WUF5, P61026, P31947, P06733, P04075, Q9H444, P43487, Q9C0C2, P30041, Q15056, P46109, P31949, Q15907, Q99497, Q9UJU6, O60437, P00338, Q92817, P31939, Q16643, P20810, Q9NYL9, P0DMV9, Q16658, P63244, Q14847, Q8NC51, Q14247
|
1.3E-12*
|
|
2
|
6.45
|
GO:0043488~regulation of mRNA stability
|
P27695, P25788, P25789, P25786, P0DMV9, P20618, P28070, O14818, Q92945, P60900, P49721, P04792, P49720, Q8NC51, P28066
|
2E-6*
|
|
3
|
6.45
|
GO:0051603~proteolysis involved in cellular protein catabolic process
|
P20618, P25788, P25789, P25786, P28070, O14818, P07858, P60900, P49721, P49720
|
1E-4*
|
|
3
|
4.23
|
GO:0006096~glycolytic process
|
P60174, P04406, P00558, P04075, P00338, P06733, P06744
|
0.026*
|
|
(B) KEGG pathways (DAVID)
|
|
1
|
6.45
|
hsa03050:Proteasome
|
P20618, P25788, P25789, P25786, P28070, O14818, P60900, P49721, P49720, P28066
|
3.6E-4*
|
|
2
|
4.23
|
hsa01130:Biosynthesis of antibiotics
|
P40925, P60174, P04406, P37837, P06733, P00338, P04075, Q03154, P06744, P31939, P11766, P54687, P29401, P14324, P00558, P14550, P21399
|
0.014*
|